Search

everythinglearnresearchcommunity

for

Search:↓

Black hairy tongue can be an early sign of graft-versus-host disease after stem cell transplants.

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

A man developed facial skin lesions after a stem cell transplant, which improved with specific treatments.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Older age and prostatic hyperplasia in males increase the risk of hemorrhagic cystitis after stem cell transplantation.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

Stem cells from fat improve dog wound healing better than standard treatment.

Early treatment with the right dose of stem cells can reduce lupus symptoms.

Skin grafts from related donors significantly healed chronic wounds in patients with a severe skin condition over a year.

"Clean" shampoos use fewer allergenic preservatives than traditional ones but still contain fragrances, and their actual risk of causing skin reactions is unclear.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

The immune system can cause permanent skin and hair whitening by attacking pigment cells.

Porphyria cutanea tarda causes skin issues due to an enzyme deficiency.

Injecting young pig stem cells can make old pig skin look younger and more elastic.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

CMV infection increases the risk of GvHD after bone marrow transplants.

Adipose-derived stem cells are promising for regenerative medicine due to their accessibility, versatility, and low risk of immune rejection.

Patients with GATA2 deficiency show early skin symptoms that help diagnose the condition.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Current skin substitutes help heal severe burns but don't fully replicate natural skin features.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

MicroRNAs could improve skin tissue engineering by regulating cells and changing the skin's bioactive environment.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Follicular Cell Implantation might become a new treatment for hair loss and could lead to advances in organ regeneration.